eli lilly and company tirzepatide sues companies selling alternative versions of its weight loss drug Eli Lilly's tirzepatide cuts heart

In contrast, semaglutide, despite its widespread clinical use for glycemic control and weight loss, showed minimal interaction with neurodegenerative pathways within the DM2-AD comorbidity network, suggesting that its metabolic benefits may not translate into AD risk reduction through core disease-associated mechanisms

To be clear, I dont think anyones claiming that this is some kind of like magical cure by itself

One of the most common complaints GPs in Australia hear is that their patients feel exhausted, and want to know how to boost their energy

Symptoms are often dose-dependent and may improve over time as the body adjusts to the medication